Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: A report from the International RRD Consortium von Das, Anirban, Fernandez, Nicholas R, Levine, Adrian, Bianchi, Vanessa, Stengs, Lucie K, Chung, Jiil, Negm, Logine, Dimayacyac, Jose Rafael, Chang, Yuan, Nobre, Liana, Ercan, Ayse B, Sanchez-Ramirez, Santiago, Sudhaman, Sumedha, Edwards, Melissa, Larouche, Valerie, Samuel, David, Van Damme, An, Gass, David, Ziegler, David S, Bielack, Stefan S, Koschmann, Carl, Zelcer, Shayna, Yalon-Oren, Michal, Campino, Gadi Abede, Sarosiek, Tomasz, Nichols, Kim E, Loret De Mola, Rebecca, Bielamowicz, Kevin, Sabel, Magnus, Frojd, Charlotta A, Wood, Matthew D, Glover, Jason M, Lee, Yi-Yen, Vanan, Magimairajan, Adamski, Jenny K, Perreault, Sebastien, Chamdine, Omar, Hjort, Magnus Aasved, Zapotocky, Michal, Carceller, Fernando, Wright, Erin, Fedorakova, Ivana, Lossos, Alexander, Tanaka, Ryuma, Osborn, Michael, Blumenthal, Deborah T, Aronson, Melyssa, Bartels, Ute, Huang, Annie, Ramaswamy, Vijay, Malkin, David, Shlien, Adam, Villani, Anita, Dirks, Peter B, Pugh, Trevor J, Getz, Gad, Maruvka, Yosef E, Tsang, Derek S, Ertl-Wagner, Birgit, Hawkins, Cynthia, Bouffet, Eric, Morgenstern, Daniel A, Tabori, Uri

Volltext